ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Regen BioPharma Reports Molecule Screening Success
August 31, 2018Regen BioPharma Inc. has identified a series of small molecule drugs that inhibit NR2F6. Regen's screening process demonstrated that its recently identified novel chemical compounds appear to inhibit NR2F6 and show potential for treating autoimmune diseas -
Regen BioPharma Sees Additional Positive Results for Modulating NR2F6 Checkpoint
May 17, 2017Regen BioPharma states that progress continues to be achieved by Regen in developing small molecule drugs that activate and inhibit NR2F6.
Pharma Sources Insight January 2025
